SMAD3 and diabetic kidney disease: Smad3 knock-out mice or Smad3 inhibitors attenuate renal fibrosis and inflammation in diabetic mice, suggesting that the TGF-β1/Smad3 signaling pathway contributes to renal fibrosis and inflammation in diabetic nephropathy [7–9].